Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

In this Healio Video Perspective from the ASCRS meeting, Brian Schwam, MD, discusses a trio of presentations investigating the Tecnis Odyssey IOL.Schwam said the Tecnis Odyssey (Johnson & Johnson ...

LENSAR and Alcon's deal presents upside and uncertainty, LENSAR for speculators, Alcon for stability. Check out more on LNSR ...